News

Pizza chains are under pressure. GLP-1 use is only one part of the problem

CNBC

Big pizza chains are struggling as weaker consumer spending, a wider variety of dining options and the rise of GLP-1 medications weigh on their sales. The pandemic was a boom time for Domino's Pizza , Papa Johns , Little Caesars and Pizza Hut. But since dining rooms reopened, the biggest U.S. pizza chains have faced an uphill battle to retain their customers. These days, consumers are watching their discretionary spending but have more delivery and takeout options when they do decide to order, thanks to the accessibility of third-party platforms. Plus, food quality and the customer experience have become more important to diners who are looking for value when they order from restaurants.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.